Regulation & Compliance

Binance's spot on the Fortune Crypto 100 is a mainstream win, but it masks a deeper story of regulatory battles and a high-stakes pivot to a financial super app.

Elwood's integration with Kalshi isn't just a tech deal; it's a growth signal that prediction markets are getting the institutional rails they need to grow up.

With Thomas Winstanley at the helm, Edibles.com eyes dominance in the wellness-THC space. Can his CPG playbook conquer a booming but volatile market?

As quantitative tightening shrinks liquidity, Sweden's central bank is telling banks to test their borrowing capacity. It's a crucial fire drill for a new era.

InstallatørGruppen's strong Nasdaq debut was a win for the green transition, but a price dip and a quick correction reveal the complex realities of going public.

Solflare Packs brings real trading cards to the blockchain, promising a seamless future. But does this digital convenience come at the cost of community and trust?

A tropical island is now a high-tech production line for AI-driven dramas. We analyze how Hainan's tax policies and tech are fueling China's global media push.

Brazil's top medical educator just posted record profits. But its real story is a radical new blueprint integrating AI and sustainability to redefine value.

W. R. Berkley's appointment of Kirk Parker isn't just a leadership shuffle; it's a calculated move to master the complex Pacific Northwest market.

Timeero's new Auto Clock-In/Out feature uses geofencing to eliminate missed punches for field teams, tackling a costly source of payroll and compliance issues.

As digital fraud grows, one company's rise to 'Leader' status, fueled entirely by user reviews, reveals what businesses truly need to secure the system.

Insurers bleed cash on flawed customer acquisition. A new AI platform from ZVOX claims to stop the waste by matching every lead with the perfect outreach.

Millions suffer from chronic sciatica with few good options. A small biotech is betting on a novel, non-opioid drug to fix the problem, not just mask it.

A major financial outlook warns that geopolitical fragmentation, stubborn inflation, and a new AI arms race are creating a new reality for investors.

Polish biotech firm Urteste S.A. enrolls its first patient in a pivotal trial for a non-invasive pancreatic cancer test, a milestone in the global race for early diagnosis.

MAIA Biotechnology isn't just opening a new trial site; it's accelerating its assault on a $70B market with a drug showing remarkable early results.

With OpenAI exec Adena Hefets on its board, Entrata isn't just hiring a director; it's signaling a radical shift toward an autonomous future for housing.

As businesses rush to advertise on ChatGPT, a critical question emerges: does it work? CallRail's new integration aims to answer that, giving SMBs the tools to measure ROI and compete in the new AI-driven landscape.

Lattice unveils new tools to measure AI's qualitative impact on performance, challenging the industry to move beyond simple usage metrics and prove real ROI.

The viral foldable home company BOXABL has secured its Nasdaq listing via a SPAC merger. But with a massive valuation and minimal cash from the deal, can it deliver?